Heightened neurologic complications in children with pandemic H1N1 influenza

Annals of Neurology

Volumn 68, Issue 5, 2010, Pages 762-766

  Ekstrand, Jeffrey J ^a   Herbener, Amy ^a   Rawlings, Julia ^a   Turney, Beth ^b   Ampofo, Krow ^a   Korgenski, E Kent ^c   Bonkowsky, Joshua L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; IMMUNOGLOBULIN; OSELTAMIVIR; STEROID;

ADOLESCENT; APHASIA; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; EEG ABNORMALITY; EPILEPTIC STATE; FEMALE; HEADACHE; HUMAN; INFLUENZA A (H1N1); MALE; MYOSITIS; NEUROLOGICAL COMPLICATION; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL INFLUENZA; SEIZURE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; NERVOUS SYSTEM DISEASES; PANDEMICS;

EID: 78249272296     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22184     Document Type: Article

References (15)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605 - 2615.
2. Centers for Disease Control and Prevention (CDC). Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 773 - 778.
3. Baltagi SA, Shoykhet M, Felmet K, et al. Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. Pediatr Crit Care Med 2010; 11: 179 - 184.
4. Webster RI, Hazelton B, Suleiman J, et al. Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports. Neurology 2010; 74: 1077 - 1078.
5. Norlin C, Osborn LM., Organizational responses to managed care: issues for academic health centers and implications for pediatric programs. Pediatrics 1998; 101 (4 pt 2): 805 - 811.
6. Rocholl C, Gerber K, Daly J, et al. Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics 2004; 113 (1 pt 1): e51 - e56.
7. Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006; 118: 2409 - 2417.
8. Morishima T, Togashi T, Yokota S, et al for the Collaborative Study Group on Influenza-Associated Encephalopathy in Japan. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002; 35: 512 - 517.
9. Maricich SM, Neul JL, Lotze TE, et al. Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics 2004; 114: e626 - e633.
10. Newland JG, Laurich VM, Rosenquist AW, et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr 2007; 150: 306 - 310.
11. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005; 294: 2188 - 2194.
12. Jain S, Kamimoto L, Bramley AM, et al for the 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935 - 1944.
13. Louie JK, Acosta M, Winter K, et al for the California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302: 1896 - 1902.
14. Studahl M., Influenza virus and CNS manifestations. J Clin Virol 2003; 28: 225 - 232.
15. Kimberlin DW, Shalabi M, Abzug MJ, et al for the NIAID Collaborative Antiviral Study Group. Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J 2010; 29: 195 - 198.